Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

  • Fulltext

    Final published version, 171 KB, PDF document

We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy. More studies are needed to characterise the incidence of inflammatory vaginitis among women on long-term rituximab therapy.

Original languageEnglish
Article numbere250425
JournalBMJ Case Reports
Volume15
Issue number11
ISSN1757-790X
DOIs
Publication statusPublished - 2022

Bibliographical note

Publisher Copyright:
© BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

    Research areas

  • Multiple sclerosis, Neurology

ID: 329305424